A randomized, parallel group, open-label, active controlled, multicenter Phase III trial of Patupilone (EP0906) versus pegylated liposomal doxorubicin (Doxil/Caelyx) in taxane/platinum refractory/resistant patients with recurrent epithelial

  • Rea, Daniel (Principal Investigator)

Project Details

Short titleA randomized, parallel group, open-label, active controlled, multicenter Phase III trial of Patupilone (EP0906) versus pegylated liposomal doxorubicin (Doxil/Caelyx) in taxane/platinum refractory/resistant patients with recurrent epithelial
StatusFinished
Effective start/end date1/06/0731/12/11

Funding

  • Sandwell & West Birmingham Hospitals